Innovation Pharmaceuticals Inc. (IPIX)

IPIX Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar 4, 2026	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019
Market Capitalization	0	10	0	93	121	38
Market Cap Growth	599.99%	2038.02%	-99.48%	-22.61%	217.11%	-58.37%
Enterprise Value	-	9	-7	82	123	40
Last Close Price	0.00	0.02	0.03	0.22	0.41	0.19
PS Ratio	-	-	26.94	-	285.59	-
PB Ratio	0.32	5.08	0.10	12.45	82.63	-9.23
P/TBV Ratio	-	259.17	0.20	19.66	-	-
EV/Sales Ratio	-	-	-	-	289.92	-
Debt / Equity Ratio	0.60	0.36	0.27	0.25	1.68	-0.68
Net Debt / Equity Ratio	-0.14	-0.39	-0.53	-1.11	-2.44	-0.54
Net Debt / EBITDA Ratio	0.09	0.31	0.40	0.96	0.84	-0.37
Net Debt / FCF Ratio	0.09	0.38	0.40	0.88	0.86	-0.35
Asset Turnover	-	-	0.00	-	0.06	-
Quick Ratio	0.17	0.30	0.79	1.56	0.82	0.08
Current Ratio	0.19	0.33	0.82	1.64	0.83	0.09
Return on Equity (ROE)	-114.34%	-93.60%	-115.06%	-309.26%	-	-
Return on Assets (ROA)	-18.42%	-20.53%	-34.23%	-47.86%	-43.58%	-74.35%
Return on Capital Employed (ROCE)	-145.70%	-117.70%	-121.30%	-116.20%	-246.70%	193.80%
Earnings Yield	-707.85%	-30.56%	-1452.10%	-14.84%	-5.50%	-22.79%
FCF Yield	-	-20.32%	-1295.15%	-10.16%	-3.44%	-16.62%
Buyback Yield / Dilution	1.42%	-0.38%	-30.48%	-61.96%	-33.78%	-23.33%

Updated Nov 20, 2023. Source: S&P Global Market Intelligence. Standard template. Financial Sources.